Elevance Health, Inc. Quarterly Report for Q3 Ended Sep 30, 2014

Summary

Elevance Health, Inc. (formerly WellPoint, Inc.) reported a solid third quarter and first nine months of 2014, demonstrating revenue growth driven by increased premium revenue in its Government Business segment and higher administrative fees in its Commercial and Specialty Business segment. Despite a slight year-over-year decrease in net income for the quarter, primarily due to the impact of the new Health Insurance Provider (HIP) Fee and lower investment income, the company's diluted Earnings Per Share (EPS) saw a modest increase due to effective share repurchase programs. The company's balance sheet reflects steady growth in total assets, supported by strong performance in investments and receivables. Liabilities also saw an increase, largely driven by policy liabilities and long-term debt, reflecting the company's strategic financial management. Significant focus was placed on managing capital through substantial share repurchases and dividend payments, underscoring a commitment to shareholder returns. The company also highlighted its strategic positioning within the evolving healthcare landscape, including the upcoming name change to Anthem, Inc., and its continued adaptation to the Affordable Care Act. Overall, Elevance Health presented a picture of financial resilience and strategic adaptation. Investors can note the consistent revenue growth, effective capital management strategies, and the company's proactive approach to navigating regulatory changes and market dynamics. While challenges such as the impact of the HIP Fee and specific segment pressures exist, the overall trajectory indicates a stable and growing enterprise.

Key Highlights

• 1Total operating revenue increased by 4.3% to $18.4 billion for the third quarter of 2014 and by 3.2% to $54.2 billion for the first nine months of 2014, driven by higher premium revenue in the Government segment and increased administrative fees in the Commercial and Specialty segment.
• 2Net income for the third quarter decreased slightly by 3.9% to $630.9 million, while net income for the first nine months decreased by 11.9% to $2.1 billion, largely impacted by the non-tax deductible Health Insurance Provider (HIP) Fee and other operational factors.
• 3Diluted Earnings Per Share (EPS) increased by 2.8% to $2.22 for the third quarter and decreased by 6.6% to $7.18 for the first nine months, with the quarterly increase driven by a lower share count due to share repurchases.
• 4The company experienced robust growth in its medical membership, increasing by 5.7% to 37.5 million members, with significant gains in Medicaid and self-funded arrangements.
• 5Operating cash flow for the first nine months of 2014 increased by 10.3% to $3.1 billion, reflecting effective management of policy liabilities and increased premium receipts.
• 6The company continued its capital return strategy, repurchasing $2.7 billion of common stock in the first nine months of 2014 and paying significant dividends, demonstrating a focus on shareholder value.
• 7Elevance Health announced plans to change its corporate name to Anthem, Inc. effective December 2014, subject to shareholder approval.

Frequently Asked Questions